東方甄選(01797.HK)首款自營衛生棉正式投產 6月16日開賣
東方甄選(01797.HK)官方公眾號公布,首款自營衛生巾正式投產,並將於6月16日開售。公司指,首款衛生巾產品為「純棉表層衛生巾」,主打安全親膚。針對消費者高度關注的衛生巾品質問題,集團表示,做衛生巾延續其一貫做自營品的嚴格標準,確保產品安全。
在生產標準方面,東方甄選表示,衛生巾生產是與產業內龍頭企業合作。同時,東方甄選在工廠多個點位設置了多台監控設備,對生產流程進行全面監控,確保每一批次的產品安全合規。
近年國內黑心衛生巾問題曝光,有報道指消費者到香港搶購衛生巾,內地男星黃子韜亦宣布自家生產衛生巾,在國內引起討論。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.